Novartis Institutes for Biomedical Research
Dr. Thierry Wendling is affiliated to Manchester Pharmacy School, Novartis Institutes for Biomedical Research. Dr. Thierry Wendling is currently providing services as Professor. Dr. Thierry Wendling has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Thierry Wendling contributions have acclaimed recognition from honourable subject experts around the world. Dr. Thierry Wendling is actively associated with different societies and academies. Dr. Thierry Wendling academic career is decorated with several reputed awards and funding. Dr. Thierry Wendling research interests include Manchester Pharmacy School.
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma.